FIDEURAM - INTESA SANPAOLO PRIVATE BANKING S.P.A.
Position in LLY — ELI LILLY & Co
CIK 1280487
TURIN, L6
Position in LLY
as of Jun 30, 2026
· filed Jul 23, 2026
Position Value
$44,983,426
+$12,368,382 QoQ
Shares Held
37,504
+5.8% QoQ
Ownership
0.004%
of shares outstanding
% of Portfolio
1.38%
of 13F equity value
Holder Rank
#577
of 4,605 holders
Holding Since
Dec 2025
3 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in LLY Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026FIDEURAM - INTESA SANPAOLO PRIVATE BANKING S.P.A. holds $204,227,443 across 9 Drug Manufacturers - General names. LLY ranks #2 (22.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | MRK |
Merck & Co., Inc.
|
416,139 | $53,473,861 | |
| 2 | LLY |
ELI LILLY & Co
This page
|
37,504 | $44,983,426 | |
| 3 | ABBV |
AbbVie Inc.
|
155,208 | $39,056,541 | |
| 4 | AMGN |
Amgen Inc
|
58,035 | $21,015,634 | |
| 5 | JNJ |
Johnson & Johnson
|
74,163 | $18,835,177 | |
| 6 | GILD |
Gilead Sciences, Inc.
|
148,589 | $18,772,734 | |
| 7 | BMY |
Bristol Myers Squibb Co
|
57,474 | $3,311,651 | |
| 8 | BIIB |
Biogen Inc.
|
15,238 | $3,292,322 |
All Filings in LLY
Export CSV
3 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $44,983,426 | 37,504 | Shares | Defined | 2026-07-23 | |
| 2026-03-31 | $32,615,044 | 35,460 | Shares | Defined | 2026-04-27 | |
| 2025-12-31 | $35,991,036 | 33,490 | Shares | Defined | 2026-02-09 | |
| No filing history on record for this holder in this stock. | ||||||